Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Warburg Pincus is backing a recapitalisation of MB2 Dental, the dental partnership organization (DPO) that supports doctor partners while preserving clinical autonomy. MB2 reported adding 108 new practices in 2024, reaching more than 750 practices by year-end.
The company said its network expansion drove 4 million patient visits in 2024 and expanded into additional states, reaching 44 states. MB2 also cited prior financing, including $2.3 billion in unitranche debt financing for future acquisitions and a $525 million Warburg Pincus investment in November 2024.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026